Buyouts Dwindle As Pharma Sector Faces Pricing Concerns
The pharmaceutical industry is currently facing various challenges, including concerns about pricing due to the Inflation Reduction Act and increased scrutiny from the Federal...
Unconstitutional Price-Setting Provisions: PhRMA Asserts
NICA, PhRMA, and GCCA lodged a complaint in the U.S. District Court for the Western District of Texas, asserting that the price setting provisions...
Pharma May Lose Out To Competition Due To EU Health Package
In a major concern surrounding Europe’s pharma industry, there is an anticipation that it could go on to lose out to elevated competition from...
Pharma Trade Group Sues Biden Admin Over Medicare Drug Costs
On June 21, the pharma sector’s biggest lobbying group, along with two major organisations, went on to sue the Biden administration when it came...
Adapting Digital Transformation In The Life Sciences Sector
To gain a competitive advantage, organizations are proactively overhauling their digital transformation strategies. It has become evident that traditional paper-based operations and fragmented data...
Cell And Gene Therapy CDMO Services Set For Rapid Growth
The global cell and gene therapy Contract Development and Manufacturing Organization (CDMO) services market, which was valued at USD 5,193.7 million in 2022, is...
Growth Forecast For Asia Pacific Pharmaceutical CDMO Market
The Asia Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market is expected to see significant growth. Factors driving this include rising pharmaceutical demand,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...



























